Stocks

Kleiner Perkins raises $3.5B, fueling AI bets. Strong returns from Figma IPO signal VC confidence.

ANI Pharma's 22% drop to $73.90 & negative ROIC raise red flags despite fair P/E.

META's revenue surges 24%, but AI costs hit earnings. P/E of 25 faces risk from margin compression.

GBX surges 14.5% to $51.94, but weak margins & negative FCF signal risk despite reasonable P/E.

Venture Global surges 5% on analyst upgrades; potential 33% gains seen amid rising LNG demand & prices.

Australia’s February CPI eased to 3.7% y/y with flat monthly growth, while core inflation softened slightly, but the data predates a surge in energy prices, leaving inflation risks and RBA tightening bias intact.

SpaceX is reportedly preparing to file its IPO prospectus, with advisers eyeing a raise of over $75bn, though the size raises questions given its already high private market valuation.